Über das Unternehmen
- Firmenname (rechtlich): Transo-Pharm Handels GmbH
- Registrierungsland: Germany
- Adresse: Bueltbek 5, 22962 Siek
- Anzahl der Mitarbeiter: 25 - 49
Beschreibung:
Transo-Pharm, founded in 1987, is a fully licensed global distributor of pharmaceutical components for health and veterinary industries. It supports customers throughout the API lifecycle, from development to sales, offering diverse products and qualifying manufacturers for compliance. Acting as a sourcing and regulatory marketing agent, Transo-Pharm has offices in Shanghai, Hong Kong, Singapore, the United States, and an affiliated office in Mumbai. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
VertriebspartnerLogistikeinheitRegulatory-Berater
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
VertriebspartnerLogistikeinheitRegulatory-Berater
Original-Wirkstoffe
VertriebspartnerLogistikeinheitRegulatory-Berater
Zulassungs- & Marktanalyse-Dienstleistungen
Dienstleister
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Hyoscine N-Butylbromide (CEP), Ajmaline (ASMF), Noscapine (ASMF), Scopolamine Hydrobromide (CEP / US-DMF), Scopolamine Methylbromide (US-DMF), Doxorubicin HCl (CEP), Epirubicin HCl ( CEP / US-DMF), Idarubicin HCl (ASMF / US-DMF), Nelarabine (US-DMF), Valrubicin (US-DMF), Epinephrine Base (CEP / US-DMF), Epinephrine Bitartrate (CEP / US-DMF), Estriol (CEP), Norepinephrine bitartrate (CEP / US-DMF), Thyroid Extract (USP), Dorzolamide HCl (CEP), Acetylcysteine (CEP), Crotamiton (CEP / US-DMF), Dexmedetomidine (ASMF), Guaifenesin (CEP / US-DMF), Hyoscine (CEP), Levosimendan (ASMF), Methocarbamol (ASMF / US-DMF), Nonivamide (ASMF), Phenylephrine HCl (CEP / US-DMF), Tranexamic Acid (CEP)
- Original-Wirkstoffe: Digoxin (CEP / US-DMF)
- Tierarzneimittel & Futtermittelzusatzstoffe: Clenbuterol HCl (CEP / US-VMF)
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
CEP-Zertifikat
DMF
GMP
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen